Figure 4.
Effects of overexpression or silencing of miR-330-3p on the expression levels of PKCα and p-PKCα in EMAP-II treated GECs. (A) The relative mRNA expression level of PKCα was detected by real-time quantitative PCR. U6 was used as an inner control. (B) Western blot analysis of the PKCα and p-PKCα levels in GECs. GAPDH was used as an inner control. *P < 0.05, **P < 0.01 vs. control group; #P < 0.05, ##P < 0.01 vs. EMAP-II group. (C) The expression and distribution of PKCα in GECs was analyzed by immunofluorescence assay. Scale bar represents 20 μm. Values are means ± SD (n = 5, each).